AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2024, quý kết thúc ngày Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
AXIM Biotechnologies's total debt was $186.49K at Jun 30, 2024. For fiscal 2023 it was $231.87K, up 1071.7% from the year before. The highest annual figure on record is $1.68M in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $231.87K | +1071.7% |
| FY2022 | Dec 31, 2022 | $19.79K | +10893.9% |
| FY2021 | Dec 31, 2021 | $180 | -100.0% |
| FY2020 | Dec 31, 2020 | $1.68M | +33439.4% |
| FY2019 | Dec 31, 2019 | $5.00K | -98.8% |
| FY2018 | Dec 31, 2018 | $412.50K | +8150.0% |
| FY2017 | Dec 31, 2017 | $5.00K | 0.0% |
| FY2016 | Dec 31, 2016 | $5.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $186.49K | +110.8% |
| Q1 FY2024 | Mar 31, 2024 | $209.34K | +4100.2% |
| Q4 FY2023 | Dec 31, 2023 | $231.87K | +1071.7% |
| Q3 FY2023 | Sep 30, 2023 | $91.67K | +50828.9% |
| Q2 FY2023 | Jun 30, 2023 | $88.48K | -93.5% |
| Q1 FY2023 | Mar 31, 2023 | $4.98K | -99.6% |
| Q4 FY2022 | Dec 31, 2022 | $19.79K | +10893.9% |
| Q4 FY2021 | Dec 31, 2021 | $180 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.37M | +140648.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.34M | +60925.7% |
| Q1 FY2021 | Mar 31, 2021 | $180 | -96.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.68M | +33439.4% |
| Q3 FY2020 | Sep 30, 2020 | $973 | -80.5% |
| Q2 FY2020 | Jun 30, 2020 | $2.19K | -56.2% |
| Q1 FY2020 | Mar 31, 2020 | $5.00K | 0.0% |
| Q4 FY2019 | Dec 31, 2019 | $5.00K | -98.8% |
| Q3 FY2019 | Sep 30, 2019 | $5.00K | -98.8% |
| Q2 FY2019 | Jun 30, 2019 | $5.00K | -60.0% |
| Q1 FY2019 | Mar 31, 2019 | $5.00K | 0.0% |
| Q4 FY2018 | Dec 31, 2018 | $412.50K | +8150.0% |
| Q3 FY2018 | Sep 30, 2018 | $412.50K | +8150.0% |
| Q2 FY2018 | Jun 30, 2018 | $12.50K | +150.0% |
| Q1 FY2018 | Mar 31, 2018 | $5.00K | 0.0% |
| Q4 FY2017 | Dec 31, 2017 | $5.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $5.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $5.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $5.00K | – |
See a number that looks wrong?